Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Nesiritide, a recombinant human B-type natriuretic peptide, has favorable effects on patient
symptoms, hemodynamics, and the neurohumoral profile in adults with decompensated congestive
heart failure and in those recovering from cardiac surgery involving cardiopulmonary bypass.
Investigators seek to determine whether nesiritide would improve the early postoperative
course after total cavo-pulmonary connection surgery in children.